28.06.2014 Views

Development and Characterization of ... - Sciensage.info

Development and Characterization of ... - Sciensage.info

Development and Characterization of ... - Sciensage.info

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Swelling Index %w/w<br />

% Microcapsules retained after<br />

8th hour<br />

Santhosh Kumar Mankala et al, J Adv Scient Res, 2011; 2(4): 34-45 43<br />

Table 3: Drug content/Encapsulation Efficiency <strong>of</strong> formulations NSM 1 -NMM 6<br />

Formulation<br />

D:SA:P<br />

ratio<br />

Weight<br />

Taken<br />

(mg)<br />

Theoretical<br />

Drug content<br />

(mg)<br />

Practical<br />

Drug Content<br />

(mg)<br />

Encapsulation<br />

Efficiency (%)<br />

NSM 1<br />

2:2:1 100 40 36.55 ±2.254 91.375 ±5.126<br />

NSM 2<br />

2:3:1 100 33.33 30.98 ±1.975 93.878 ±4.356<br />

NSM 3<br />

2:4:1 100 28.57 25.36 ±1.991 90.571 ±4.198<br />

NMM 4<br />

2:2:1 100 40 34.58 ±2.321 86.45 ±6.124<br />

NMM 5<br />

2:3:1 100 33.33 30.24 ±1.012 91.636 ±2.448<br />

NMM 6<br />

2:4:1 100 28.57 22.65 ±3.165 80.892 ±7.275<br />

*Mean ± S.D (n=3)<br />

250<br />

200<br />

150<br />

110.54<br />

Swelling Index data <strong>of</strong> nateglinide mucoadhesive<br />

microcapsules (Formulations NSM1-NMM6)<br />

163.44<br />

189.29<br />

104.3<br />

132.3<br />

30<br />

25<br />

20<br />

15<br />

In vitro mucoadhesive wash <strong>of</strong> test results <strong>of</strong> nateglinide<br />

mucoadhesive microcapsules after 8hours<br />

(Formulations NSM1-NMM6) 24<br />

18<br />

22<br />

20<br />

18<br />

20<br />

100<br />

57.89<br />

10<br />

50<br />

5<br />

0<br />

NSM1 NSM2 NSM3 NMM4 NMM5 NMM6<br />

Formulations<br />

0<br />

NSM1 NSM2 NSM3 NMM4 NMM5 NMM6<br />

Formulation<br />

Figure 5: Swelling Index histogram <strong>of</strong> nateglinide mucoadhesive<br />

microcapsules NSM 1 -NMM 6<br />

All physical parameters were found in the acceptable range.<br />

The microencapsulation efficiency <strong>and</strong> swelling index were<br />

found to be greater with Sod. CMC than in other formulations,<br />

whereas mucoadhesive efficiency was found higher in<br />

formulations with MC. All compositions were found<br />

compatible in IR, DSC <strong>and</strong> XRD studies <strong>and</strong> thus are suitable<br />

for extending the scope <strong>of</strong> work in this research area. The<br />

drug release from the microcapsules was sustained over an<br />

Figure 6: In vitro mucoadhesive wash <strong>of</strong>f test results histogram<br />

<strong>of</strong> nateglinide mucoadhesive microcapsules NSM 1 -NMM 6 after 8<br />

h<br />

extended period <strong>of</strong> time. The study states that release<br />

depended on the core: coat ratio <strong>and</strong> type <strong>of</strong> mucoadhesive<br />

agent, which got retarded as the coat material percentage got<br />

increased. Microcapsules prepared using Sod. CMC showed<br />

better sustained action, <strong>and</strong> formulation containing drug: SA:<br />

Sod. CMC in the ratio 2:4:1 was found to be the best<br />

formulation as it released the maximum drug up to 22 h.<br />

Table 4: In Vitro Wash <strong>of</strong>f Test Data <strong>of</strong> formulations NSM 1 -NSM 6<br />

Formulation<br />

(50<br />

microcapsules)<br />

% <strong>of</strong> microcapsules (±SD) adhering to tissue at (h)<br />

Phosphate buffer, pH 7.4<br />

1 2 4 8<br />

NSM 1 52 ±4.66 44 ±2.66 34 ±2 18 ±3.33<br />

NSM 2 68 ±5.33 56 ±4 44 ±3.33 22 ±2.66<br />

NSM 3 82 ±5 68 ±4.33 58 ±4.66 20 ±1.66<br />

NMM 4 52 ±3.33 44 ±4.33 34 ±2.66 18 ±3<br />

NMM 5 62 ±2.66 56 ±2.66 43 ±3.33 24 ±3.66<br />

NMM 6 76 ±4.66 62 ±4 48 ±2.66 20 ±2.66<br />

*Mean ± S.D (n=3)<br />

Journal <strong>of</strong> Advanced Scientific Research, 2011, 2(4)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!